Chromosomal proteins from the embryoid body/teratocarcinoma system.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to D B Carter.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A group of arylalkylboronic acids were synthesized in order to investigate the inhibitory potential of these compounds for rat liver chromatin protease (EC 3.4--). The effect of side chain length, side chain substitution and aromatic substitution on proteolytic activity in chromatin dissociated in salt and urea was assayed. It was determined that a side chain length two carbons long provided the greatest inhibitory effect with complete inhibition attainable at 20 mM concentration of phenylethylboronic acid. Aryl substitution in the ortho position proved to be the most potent structural change with complete inhibition attained by 1 mM concentration of 0-methylphenylethylboronic acid. The binding of these two inhibitors proved to be reversible.
The nuclei and chromatin of rat liver contain three major proteins reacting with diisopropyl fluorophosphate (DFP). The molecular weights of the three proteins determined by gel filtration in the presence of sodium dodecyl sulfate and sodium dodecyl sulfate-polyacrylamide gel electrophoresis are 70000, 60000, and 25000. The chromatin isolated from whole liver, instead of nuclei, contains an additional DFP-binding protein whose molecular weight is 100000 in the presence of sodium dodecyl sulfate and beta-mercaptoethanol. The small molecular weight DFP-binding protein can be fractionated from chromatin by 0.25 N HC1 and was found to be a protease which is active in the most commonly used solution for chromatin dissociation, that is, 2-3 M NaCl-5 M urea. This enzyme appears to be the major DFP-binding chromatin-bound protease in the chromatin of most rat tissues. The acid-soluble protease is converted from a 25000-dalton form to a 20000-dalton form during 0.25 N HC1 acid extraction from chromatin, which retains proteolytic activity.
A chromatin-bound protease, active in 2 M NaCl-5 M urea or 5 M urea alone, was demonstrated in rat liver, kidney, testes, brain, rabbit bone marrow, chicken reticulocyte, and Ehrlich ascites chromatin. Chicken erythrocyte chromatin did not possess any detectable proteolytic activity in salt and urea. The proteolytic activity of rat liver chromatin in salt and urea was found to be independent of the methods of chromatin preparation. The protease can be inhibited by the serine specific reagents phenylmethanesulfonyl fluoride and diisopropyl fluorophosphate and the alkylating reagent, carbobenzoxyphenylalanine chloromethyl ketone, in the presence of organic solvents at 1 mM concentration. The inhibitions of chromatin-bound protease in rat liver by these compounds are irreversible. On the other hand, carbobenzoxyphenylalanine and p-nitrophenyl acetate were shown to be reversible inhibitors of rat liver chromatin-bound protease. The application of these inhibitors during the dissociation of chromatin by salt and urea may be useful to researchers interested in purifying various chromosomal proteins or to those researchers doing reconstitution studies with labile chromatins.
Explore the source record for details and available documents.
In contrast to the earlier reports on the age-dependent reduction of the ratio of F3 plus F2al plus F2a2 / Fl plus F2b in rat liver histones and the reduction of arginine-rich histone (F3 or III) in beef thymus, the result obtained by high-resolution polyacrylamide gel electrophoresis of histones shows no apparent age-related change in the proportion of any histone fraction of mouse and rat liver chromatin.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.